These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 28809747
1. Oxidation of PTH: in vivo feature or effect of preanalytical conditions? Ursem SR, Vervloet MG, Hillebrand JJG, de Jongh RT, Heijboer AC. Clin Chem Lab Med; 2018 Jan 26; 56(2):249-255. PubMed ID: 28809747 [Abstract] [Full Text] [Related]
2. Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients. Tepel M, Armbruster FP, Grön HJ, Scholze A, Reichetzeder C, Roth HJ, Hocher B. J Clin Endocrinol Metab; 2013 Dec 26; 98(12):4744-51. PubMed ID: 24171919 [Abstract] [Full Text] [Related]
3. Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients. Hocher B, Oberthür D, Slowinski T, Querfeld U, Schaefer F, Doyon A, Tepel M, Roth HJ, Grön HJ, Reichetzeder C, Betzel C, Armbruster FP. Kidney Blood Press Res; 2013 Dec 26; 37(4-5):240-51. PubMed ID: 23868100 [Abstract] [Full Text] [Related]
4. Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD. Zeng S, Querfeld U, Feger M, Haffner D, Hasan AA, Chu C, Slowinski T, Bernd Dschietzig T, Schäfer F, Xiong Y, Zhang B, Rausch S, Horvathova K, Lang F, Karl Krämer B, Föller M, Hocher B. FASEB J; 2020 Nov 26; 34(11):15269-15281. PubMed ID: 32964520 [Abstract] [Full Text] [Related]
5. Non-oxidized PTH (n-oxPTH) is associated with graft loss in kidney transplant recipients. Lu YP, Zeng S, Chu C, Hasan AA, Slowinski T, Yin LH, Krämer BK, Hocher B. Clin Chim Acta; 2020 Sep 26; 508():92-97. PubMed ID: 32413401 [Abstract] [Full Text] [Related]
6. Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients. Zuo J, Hasan AA, Hocher CF, Kalk P, Kleuser B, Krämer BK, Hocher B. Front Endocrinol (Lausanne); 2023 Sep 26; 14():1178166. PubMed ID: 37324252 [Abstract] [Full Text] [Related]
8. Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies. Li M, Hasan AA, Chu C, Hocher JG, Liu Y, Zhang X, Chen X, Yard B, Krämer BK, Hocher B. Pflugers Arch; 2024 Jun 26; 476(6):889-899. PubMed ID: 38393416 [Abstract] [Full Text] [Related]
15. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Hermsen D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Müller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmüller T, Troch T, Bergmann P. Clin Lab; 2002 Aug 28; 48(3-4):131-41. PubMed ID: 11934215 [Abstract] [Full Text] [Related]
16. Measuring parathyroid hormone (PTH) in patients with oxidative stress--do we need a fourth generation parathyroid hormone assay? Hocher B, Armbruster FP, Stoeva S, Reichetzeder C, Grön HJ, Lieker I, Khadzhynov D, Slowinski T, Roth HJ. PLoS One; 2012 Aug 28; 7(7):e40242. PubMed ID: 22792251 [Abstract] [Full Text] [Related]